OAM
UTHR icon

Oxford Asset Management’s United Therapeutics UTHR Stock Holding History

Oxford Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
+432
New +$243K 0.12% 276
2025
Q3 		– Sell
-3,598
Closed -$1.03M – 754
2025
Q2 		$1.03M Buy
+3,598
New +$1.08M 0.34% 59
2020
Q1 		– Sell
-23,088
Closed -$2.03M – 1255
2019
Q4 		$2.03M Sell
23,088
-2,890
-11% -$254K 0.06% 408
2019
Q3 		$2.07M Buy
25,978
+10,911
+72% +$879K 0.05% 518
2019
Q2 		$1.18M Buy
+15,067
New +$1.41M 0.03% 894
2017
Q3 		– Sell
-29,032
Closed -$3.77M – 1717
2017
Q2 		$3.77M Buy
29,032
+16,682
+135% +$2.08M 0.08% 280
2017
Q1 		$1.67M Sell
12,350
-714
-5% -$108K 0.04% 576
2016
Q4 		$1.87M Sell
13,064
-152,647
-92% -$19.5M 0.07% 343
2016
Q3 		$19.6M Buy
165,711
+11,435
+7% +$1.37M 0.6% 31
2016
Q2 		$16.3M Buy
154,276
+59,246
+62% +$6.61M 0.54% 31
2016
Q1 		$10.6M Sell
95,030
-6,824
-7% -$864K 0.3% 62
2015
Q4 		$16.1M Buy
101,854
+4,569
+5% +$665K 0.38% 39
2015
Q3 		$12.8M Sell
97,285
-1,661
-2% -$266K 0.4% 40
2015
Q2 		$17.2M Sell
98,946
-8,340
-8% -$1.5M 0.47% 27
2015
Q1 		$18.5M Buy
107,286
+3,074
+3% +$469K 0.47% 31
2014
Q4 		$13.5M Sell
104,212
-4,370
-4% -$563K 0.3% 53
2014
Q3 		$14M Buy
108,582
+75,674
+230% +$7.8M 0.32% 53
2014
Q2 		$2.91M Buy
+32,908
New +$3.16M 0.09% 304
2014
Q1 		– Sell
-189,533
Closed -$21.4M – 777
2013
Q4 		$21.4M Buy
+189,533
New +$17.1M 0.54% 22
2013
Q3 		– Sell
-9,666
Closed -$636K – 904
2013
Q2 		$636K Buy
+9,666
New +$623K 0.02% 662

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Oxford Asset Management's UTHR Position: Q2 2026 in Review

Oxford Asset Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 432 shares worth $234K. The stake represents 0.12% of the portfolio and ranks #276 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in UTHR as recently as Q2 2025.

Oxford Asset Management first reported a position in UTHR in Q2 2013 and has held it in 20 quarters since. The position peaked at $21.4M in Q4 2013. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Oxford Asset Management held 432 shares of United Therapeutics worth $234K as of Q2 2026.
  • United Therapeutics was a new Oxford Asset Management position in Q2 2026.
  • United Therapeutics made up 0.12% of Oxford Asset Management's portfolio in Q2 2026, its #276 holding.
  • Oxford Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 20 quarters since.
  • Oxford Asset Management's United Therapeutics position peaked at $21.4M in Q4 2013.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.